A new report from the Nordic Expert Group (NEG) and the Dutch Expert DECOS committee has evaluated the health hazards and calculated cancer risk of occupational exposure to respirable crystalline silica (RCS). Several experts ...
Sep 10, 2024
0
0
Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is advanced, making successful treatment ...
Sep 10, 2024
0
0
The ROS1 tyrosine kinase inhibitor (TKI) taletrectinib demonstrated high overall and intracranial responses, and a favorable safety profile with low incidence of neurologic adverse events in TKI-naive and TKI-pretreated patients ...
Sep 10, 2024
0
0
The c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an acceptable safety profile in patients of Asian race with c-Met protein-overexpressing, epidermal growth factor receptor ...
Sep 10, 2024
0
0
Recent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure may significantly impact lung cancer in women who have never smoked, with notable differences in stage IV diagnoses among ...
Sep 10, 2024
0
0
A Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy and immunotherapy (in combination ...
Sep 10, 2024
0
0
For adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to a study published online Sept. 5 in The ...
Sep 10, 2024
0
0
An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC) and the Department of Molecular Biology has derived a molecular signature from tumor transcriptomics data that quantifies ...
Sep 10, 2024
0
7
As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that efforts to cap prescription drug spending are yielding ...
Sep 10, 2024
0
0
A common diabetes medication, metformin, slows the growth of precancerous cells in the esophagus while some metabolic conditions accelerate it, suggests a new study.
Sep 10, 2024
0
37
